Puma Biotechnology, Inc. (PBYI) vs ProKidney Corp. (PROK)
Puma Biotechnology, Inc. and ProKidney Corp. are both Biotechnology companies. Puma Biotechnology, Inc. and ProKidney Corp. are of similar size ($514.0M and $506.9M). ProKidney Corp. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.1×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −10,288.4%) and the higher return on invested capital (42.6% vs 0.00%). Across the 14 metrics below, Puma Biotechnology, Inc. leads on 11 and ProKidney Corp. on 3.
Valuation
Profitability
| Metric | PBYI | PROK | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.83% | 100.00% | 65.16% |
| Operating margin | 13.16% | (21,664.55%) | 0.00% |
| Net margin | 11.55% | (10,288.39%) | 0.00% |
| Free cash flow margin | 17.79% | (17,300.61%) | 0.00% |
| Return on equity | 21.97% | 8.92% | (57.72%) |
| Return on assets | 13.78% | (27.10%) | (49.22%) |
| Return on invested capital | 42.61% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack